594 results on '"Wilkins, Chris"'
Search Results
152. Measuring drug harm in New Zealand: a stocktake of current data sources.
153. A ‘community enterprise’ model for recreational cannabis: Lessons from alcohol licensing trusts in New Zealand
154. Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009
155. The association between spending on methamphetamine/amphetamine and cannabis for personal use and earnings from acquisitive crime among police detainees in New Zealand
156. Assessing New Zealand’s Cannabis Legalization and Control Bill: prospects and challenges
157. THE NEO-PERFORMATIVE TEACHER: SCHOOL REFORM, ENTREPRENEURIALISM AND THE PURSUIT OF EDUCATIONAL EQUITY
158. Investigating the New Zealand policy response to methamphetamine‐contaminated houses
159. Could the community trust model be applied to regulate cannabis? Findings from a survey of two alcohol licensing trust communities in New Zealand
160. Exploring the Adjudication of Methamphetamine-related Housing Contamination Cases in New Zealand.
161. Cannabis ‘tinny’ houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand
162. Therapeutic Role Of Cardiac Rehabilitation In Improving Cardiovascular Disease Risk Factors: 2351 11:45 AM – 12:00 PM
163. Examining the blurred boundaries between medical and recreational cannabis:Results from an international study of small-scale cannabis cultivation
164. Examining the blurred boundaries between medical and recreational cannabis : Results from an international study of small-scale cannabis cultivation
165. Organized crime in cannabis cultivation in New Zealand: an economic analysis.
166. A 'new institutional economics' approach to the reliability of street-level drug transactions.
167. Monitoring Drugs in New Zealand
168. New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?
169. Your letters.
170. Monitoring drugs in New Zealand
171. Spatial, temporal and socioeconomic patterns of illicit drug use in New Zealand assessed using wastewater-based epidemiology timed to coincide with the census.
172. Predictors of medicinal cannabis users' willingness to utilise a new prescription Medicinal Cannabis Scheme in New Zealand.
173. The New Zealand Illicit Drug Harms Index: how can it inform a health-based approach to drug use?
174. Assessing New Zealand's Cannabis Legalization and Control Bill: prospects and challenges.
175. 'Facebook probably knows I sell drugs' - how young people's digital footprints can threaten their future prospects.
176. Accurate LPG analysis begins with sampling procedures, equipment
177. Exploring medicinal use of cannabis in a time of policy change in New Zealand.
178. Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory
179. LETTERS.
180. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand
181. Examining the blurred boundaries between medical and recreational cannabis – results from an international study of small-scale cannabis cultivators
182. School autonomy reform in Queensland: governance, freedom and the entrepreneurial leader
183. Performance Metric for Turbine Stage Under Unsteady Pulsating Flow Environment
184. Performance Characterization of Twin-Scroll Turbine Stage for Vehicular Turbocharger Under Unsteady Pulsating Flow Environment
185. “Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand
186. View from the Sky: Mapping corn nitrogen status at the watershed level
187. Classical Patents - Stay In Or Opt Out?
188. Neuseeland und die Regulierung von Neuen Psychoaktiven Substanzen
189. Thirty-one psychoactive plants exempted from New Zealand'sPsychoactive Substances Act2013
190. Recent developments with the New Zealand regulated market approach to ‘low-risk’ psychoactive products
191. Performance Metric for Turbine Stage Under Unsteady Pulsating Flow Environment
192. Performance Characterization of Twin Scroll Turbine Stage for Vehicular Turbocharger Under Unsteady Pulsating Flow Environment
193. Do police arrestees substitute legal highs for other drugs?
194. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties
195. Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators
196. Vocational Education and Training in England: Opportunities and challenges in a fragmented neoliberal system.
197. Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?
198. Responding to a new wave of high potency synthetic cannabinoids.
199. School autonomy reform in Queensland: governance, freedom and the entrepreneurial leader.
200. Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.